DEBIOPHARM INNOVATION FUND
Debiopharm Innovation Fund invests in digital health companies that have an impact on cancer, infectious diseases, and drug development. We are looking for ambitious entrepreneurs raising series A or B with clinically proven, transformative technologies that use AI and data to help patients. We do not invest in consumer wellness or workflow solutions. Our initial investment is typically $2-5M. Along with capital we bring deep pharma knowledge & networks and long-term commitment to help build value in your company. We are an evergreen investment fund of the pharmaceutical company Debiopharm based in Lausanne, Switzerland.
DEBIOPHARM INNOVATION FUND
Industry:
Venture Capital
Founded:
1979-01-01
Status:
Active
Contact:
418-650-3535
Email Addresses:
[email protected]
Technology used in webpage:
Apple Mobile Web Clips Icon Amazon ASP.NET IIS Amazon Virginia Region Java EE Lorem Ipsum WordPress 5.8 Apple Whitelist IIS 7
Similar Organizations
North East Technology Fund
North East Technology Fund is a venture capital firm invests in technology businesses.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-09 | Mika | Debiopharm Innovation Fund investment in Series A - Mika | 10 M EUR |
| 2022-03-30 | VivoSense | Debiopharm Innovation Fund investment in Series A - VivoSense | 25 M USD |
| 2022-03-22 | Nucleai | Debiopharm Innovation Fund investment in Series B - Nucleai | 33 M USD |
| 2022-01-13 | VeriSIM Life | Debiopharm Innovation Fund investment in Series A - VeriSIM Life | 15 M USD |
| 2021-11-09 | Mekonos | Debiopharm Innovation Fund investment in Series A - Mekonos | 25 M USD |
| 2021-02-18 | Carevive Systems | Debiopharm Innovation Fund investment in Series C - Carevive Systems | 18 M USD |
| 2020-11-20 | Voluntis | Debiopharm Innovation Fund investment in Post-IPO Equity - Voluntis | N/A |
| 2020-09-09 | Oncomfort | Debiopharm Innovation Fund investment in Series A - Oncomfort | 10 M EUR |
| 2020-07-07 | Nucleai | Debiopharm Innovation Fund investment in Series A - Nucleai | 8.5 M USD |
| 2020-02-13 | Carevive Systems | Debiopharm Innovation Fund investment in Series C - Carevive Systems | 14.96 M USD |
More informations about "Debiopharm Innovation Fund"
Startup funding - Debiopharm
“At Debiopharm, we foresee a future where data sets the stage for the entire value chain of drug development, from generating novel drug designs to predicting clinical trial outcomes. The future of healthcare will be redesigned …See details»
Debiopharm Innovation Fund - Crunchbase
Debiopharm Innovation Fund invests in digital health companies that have an impact on cancer, infectious diseases, and drug development. We are looking for ambitious entrepreneurs raising series A or B with clinically proven, …See details»
Debiopharm Innovation Fund: the New Name and Investment …
Mar 7, 2017 Part of Debiopharm Groupâ„¢, a Swiss-headquartered global biopharmaceutical group of five companies, Debiopharm Innovation Fund’s mission is to invest in companies …See details»
Debiopharm Innovation Fund: A €141+ million …
Sep 29, 2023 Debiopharm Innovation Fund is eager to support young Seed startups by providing not only capital but also the wealth of knowledge garnered from years of investing at the nexus of technology, pharma R&D …See details»
Planting seeds of success: A new early-stage fund in …
Nov 26, 2024 Debiopharm Innovation Fund, the Swiss biopharma’s strategic investing arm managing a $150 million fund, is looking to get involved earlier in the investment process with the launch of a new seed ...See details»
Debiopharm Innovation Fund: a new seed fund …
About Debiopharm Innovation Fund. Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, provides funding and guidance for companies with an ambition to improve the patient …See details»
Debiopharm Innovation Fund investment portfolio
Jan 1, 2021 Founded in 2008, Debiopharm Innovation Fund is the corporate venture capital arm of Debiopharm Group based in Lausanne, Switzerland. The firm seeks to invest in companies developing smart data technologies applied …See details»
Debiopharm Innovation Fund Launches New Seed …
Sep 28, 2023 Kicks off fund with two strategic investments. Lausanne, Switzerland – September 28th, 2023 – Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 …See details»
An Innovation Fund lead by Entrepreneurs: …
Oct 26, 2021 Tanja Dowe is the CEO of Debiopharm Innovation Fund, the strategic investment arm of the Swiss pharmaceutical company Debiopharm. The Fund invests in digital health, smart data, and innovative tech start-ups. …See details»
Debiopharm Innovation Fund Launches New Seed Funding …
Sep 28, 2023 Kicks off fund with two strategic investments. LAUSANNE, Switzerland–(BUSINESS WIRE)–Debiopharm Innovation Fund, the strategic investment arm …See details»
Debiopharm Innovation Fund - EU-Startups
Debiopharm Innovation Fund. Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical …See details»
Debiopharm to invest in seed stage companies - startupticker.ch
Sep 28, 2023 Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million under management, launched …See details»
Debiopharm Innovation Fund S.A. - life-sciences-europe.com
Jan 1, 2008 Part of Debiopharm Groupâ„¢ – a Swiss-headquartered global biopharmaceutical group including five companies active in the life science areas of drug development, GMP …See details»
Debiopharm Innovation Fund Launches New Seed Funding …
Sep 28, 2023 LAUSANNE, Switzerland, September 28, 2023--Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million …See details»
Debiopharm Innovation Fund: latest news and updates
Debiopharm Innovation Fund welcomes StratifAI to their portfolio. Read more July 22, 2024 VeriSIM Life’s AI platform wants to speed up drug discovery. Read more July 10, 2024 Concr …See details»
Debiopharm Innovation Fund — 29 Investments, 5 Exits, 25 …
This organization was formed by Tanja Dowe. We also calculated 4 valuable employees in our database. The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the …See details»
Debiopharm Innovation Fund - Fasken
Debiopharm Innovation Fund Closed June 2023 On June 22, 2023, Altis Labs Inc., a computational imaging company accelerating clinical trials with artificial intelligence, …See details»
Debiopharm - We develop for patients and their quality of life
Debiopharm is now a group of three companies active in drug development (Debiopharm International), drug manufacturing (Debiopharm Research & Manufacturing) and digital health …See details»
Debiopharm Innovation Funds invests to accelerate the ... - BioAlps
Nov 19, 2024 Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, provides strategic funding and guidance for …See details»